» Articles » PMID: 31935523

Stability and Bioactivity of PepCD47 Attachment on Stainless Steel Surfaces

Overview
Journal Acta Biomater
Publisher Elsevier
Date 2020 Jan 15
PMID 31935523
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

In-stent restenosis (ISR) and late stent thrombosis are the major complications associated with the use of metal stents and drug eluting stents respectively. Our lab previously investigated the use of peptide CD47 in improving biocompatibility of bare metal stents in a rat carotid stent model and our results demonstrated a significant reduction in platelet deposition and ISR. However, this study did not characterize the stability of the pepCD47 on metal surfaces post storage, sterilization and deployment. Thus, the objective of the present study was 1) to test the stability of the peptide post - storage, sterilization, exposure to shear and mechanical stress and 2) to begin to expand our current knowledge of pepCD47 coated metal surfaces into the preclinical large animal rabbit model. Our results show that the maximum immobilization density of pepCD47 on metal surfaces is approximately 350 ng/cm. 100% of the pepCD47 was retained on the metal surface post 24 weeks of storage at 4 °C, exposure to physiological shear stress, and mechanical stress of stent expansion. The bioactivity of the pepCD47 was found to be intact post 24 weeks of storage and ethylene oxide sterilization. Finally our ex vivo studies demonstrated that compared to bare metal the rabbit pepCD47 coated surfaces showed - 45% reduced platelet adhesion, a 10-fold decrease in platelet activation, and 93% endothelial cell retention. Thus, our data suggests that pepCD47 coating on metal surfaces is stable and rabbit pepCD47 shows promising preliminary results in preventing thrombosis and not inhibiting the growth of endothelial cells. STATEMENT OF SIGNIFICANCE: Biocompatibility of bare metal stents is a major challenge owing to the significantly high rates of in-stent restenosis. Previously we demonstrated that peptide CD47 functionalization improves the biocompatibility of bare metal stents in rat model. A similar trend was observed in our ex vivo studies where rabbit blood was perfused over the rabbit pepCD47 functionalized surfaces. These results provide valuable proof of concept data for future in vivo rabbit model studies. In addition, we investigated stability of the pepCD47 on metal surface and observed that pepCD47 coating is stable over time and resistant to industrially relevant pragmatic challenges.

Citing Articles

Hypercholesterolemia exacerbates in-stent restenosis in rabbits: Studies of the mitigating effect of stent surface modification with a CD47-derived peptide.

Fishbein I, Inamdar V, Alferiev I, Bratinov G, Zviman M, Yekhilevsky A Atherosclerosis. 2024; 390:117432.

PMID: 38241977 PMC: 10939830. DOI: 10.1016/j.atherosclerosis.2023.117432.


Blockade of CD47 function attenuates restenosis by promoting smooth muscle cell efferocytosis and inhibiting their migration and proliferation.

Govatati S, Pichavaram P, Kumar R, Rao G J Biol Chem. 2023; 299(4):104594.

PMID: 36898577 PMC: 10124914. DOI: 10.1016/j.jbc.2023.104594.


Immunomodulatory IL-23 receptor antagonist peptide nanocoatings for implant soft tissue healing.

Pizarek J, Fischer N, Aparicio C Dent Mater. 2023; 39(2):204-216.

PMID: 36642687 PMC: 9899321. DOI: 10.1016/j.dental.2023.01.001.


Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization.

Inamdar V, Fitzpatrick E, Alferiev I, Levy R, Stachelek S, Fishbein I J Vis Exp. 2020; (166).

PMID: 33346187 PMC: 8764910. DOI: 10.3791/61545.

References
1.
Boiano J, Steege A . Ethylene Oxide and Hydrogen Peroxide Gas Plasma Sterilization: Precautionary Practices in U.S. Hospitals. Zentralsterilisation (Wiesb). 2015; 23(4):262-268. PMC: 4651664. View

2.
Stachelek S, Finley M, Alferiev I, Wang F, Tsai R, Eckells E . The effect of CD47 modified polymer surfaces on inflammatory cell attachment and activation. Biomaterials. 2011; 32(19):4317-26. PMC: 3108143. DOI: 10.1016/j.biomaterials.2011.02.053. View

3.
Torii S, Nakazawa G, Ijichi T, Yoshikawa A, Ohno Y, Ikari Y . Comparison of the endothelial coverage in everolimus and zotarolimus-eluting stents in normal, atherosclerotic, and bifurcation rabbit iliac arteries. Cardiovasc Interv Ther. 2016; 33(1):55-61. DOI: 10.1007/s12928-016-0437-6. View

4.
Chao M, Weissman I, Majeti R . The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications. Curr Opin Immunol. 2012; 24(2):225-32. PMC: 3319521. DOI: 10.1016/j.coi.2012.01.010. View

5.
Rogez-Kreuz C, Yousfi R, Soufflet C, Quadrio I, Yan Z, Huyot V . Inactivation of animal and human prions by hydrogen peroxide gas plasma sterilization. Infect Control Hosp Epidemiol. 2009; 30(8):769-77. DOI: 10.1086/598342. View